← Leaderboards
William S Weintraub
Emory University
$9,256,015
Attributed
$11,406,542
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2009–21$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$11,406,542 · 5
By mechanism
RC2$4,026,764 · 1
U54$3,746,855 · 1
R01$3,605,791 · 2
M01$27,132 · 1
Top collaborators
- Adam P Bress4 shared
- Andrew Edward Moran4 shared
Most similar at Emory University
Same institution · by research overlap
- Sampath Parthasarathy$11,379,014
- Thomas F Clasen$13,569,496
- Guangjie Cheng$3,899,168
- Robert A Swerlick$2,148,512
- Virgil W Brown$1,942,901
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsDesignInnovationResourcesClinical ResearchParticipantEpidemiologyHealthcare SystemsUniversitiesResearch PersonnelResearch InstituteInstitutionCollaborationsProviderEnvironmentBaseEpidemiologistDrug DiscoveryHealthcareCommunity OutreachCommunity Based Participatory ResearchCostBiostatistics CoreCommunities
Grant awards (13)
Patient Level Prediction of Clinical Outcomes and Cost-Effectiveness in SPRINT (Optimize-SPRINT)$762,748
R01 · FY2021 · HL
Patient Level Prediction of Clinical Outcomes and Cost-Effectiveness in SPRINT (Optimize-SPRINT)$775,853
R01 · FY2020 · HL
Patient Level Prediction of Clinical Outcomes and Cost-Effectiveness in SPRINT (Optimize-SPRINT)$794,534
R01 · FY2019 · HL
Patient Level Prediction of Clinical Outcomes and Cost-Effectiveness in SPRINT (Optimize-SPRINT)$892,656
R01 · FY2018 · HL
Clinical Research Design, Epidemiologv and Biostatistics Core$812,896
U54 · FY2017 · GM · contact PI
Clinical Research Design, Epidemiologv and Biostatistics Core$812,896
U54 · FY2016 · GM · contact PI
Clinical Research Design, Epidemiologv and Biostatistics Core$812,896
U54 · FY2015 · GM · contact PI
Clinical Research Design, Epidemiologv and Biostatistics Core$627,278
U54 · FY2014 · GM · contact PI
Clinical Research Design, Epidemiologv and Biostatistics Core$680,889
U54 · FY2013 · GM · contact PI
ACCF-STS Database Collaboration on the Comparative Effectiveness of PCI and CABG$1,370,768
RC2 · FY2010 · HL · contact PI
ACCF-STS Database Collaboration on the Comparative Effectiveness of PCI and CABG$2,655,996
RC2 · FY2009 · HL · contact PI
Serum Marker of Oxidative Stress &Vascular Inflammation$27,132
M01 · FY2004 · RR
EXERCISE AND CARDIOVASCULAR DISEASE$380,000
R01 · FY2003 · HL